HRT Financial’s Aethlon Medical AEMD Stock Holding History

HRT Financial’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,612	Closed	-$97K	–	3109
2025 Q3	$97K	Buy	+2,612	New	+$151K	﹤0.01%	2527
2025 Q2	–	Sell	-50	Closed	-$7K	–	2519
2025 Q1	$7K	Buy	+50	New	+$11.6K	﹤0.01%	2374
2024 Q3	–	Sell	-25	Closed	-$5K	–	2337
2024 Q2	$5K	Buy	+25	New	+$9.85K	﹤0.01%	2039
2023 Q4	–	Sell	-4	Closed	-$3K	–	2243
2023 Q3	$3K	Buy	+4	New	+$5.13K	﹤0.01%	2213
2023 Q2	–	Sell	-27	Closed	-$41K	–	2376
2023 Q1	$41K	Buy	27 +1	+4%	+$1.88K	﹤0.01%	2141
2022 Q4	$28K	Buy	+26	New	+$47.4K	﹤0.01%	2149

Other funds holding AEMD

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

HRT Financial's AEMD Position: Q4 2025 in Review

HRT Financial sold out of Aethlon Medical (AEMD) in Q4 2025, closing a stake of 2,612 shares — an estimated $97K sold.

HRT Financial first reported a position in AEMD in Q4 2022 and held it in 6 quarters. The position peaked at $97K in Q3 2025. 7 funds tracked by Wall St. Rank hold AEMD as of Q4 2025.

HRT Financial reported no remaining Aethlon Medical position as of Q4 2025 after selling out during the quarter.
HRT Financial sold 2,612 Aethlon Medical shares in Q4 2025, an estimated $97K.
HRT Financial first reported a position in Aethlon Medical in Q4 2022 and held it in 6 quarters.
HRT Financial's Aethlon Medical position peaked at $97K in Q3 2025.
7 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.